143 Episoade

  1. Angiosarcoma Essentials

    Publicat: 18.12.2024
  2. The Lines of Therapy After Progression on CDK4/6 Inhibitors Plus Endocrine Therapy to Overcome the Resistance in HR+/Her2 - Metastatic Breast Cancer Patients

    Publicat: 12.12.2024
  3. Women’s Health Frontiers: Breakthroughs from ESMO 2024

    Publicat: 28.11.2024
  4. ESMO Congress Prostate Cancer Highlights

    Publicat: 14.11.2024
  5. How to interpret prognostic models papers in hematology and oncology

    Publicat: 31.10.2024
  6. Stage III Lung Cancer Resecability

    Publicat: 17.10.2024
  7. Exercise, Diet, and Weight Management During Cancer Treatment: ASCO Guideline

    Publicat: 03.10.2024
  8. Clinical approach and therapeutic overview on gastroenteropancreatic neoendocrine tumours (GEP-NENS)

    Publicat: 19.09.2024
  9. Fear of recurrence: one of the major elements in reactivating cancer

    Publicat: 25.07.2024
  10. Immunohistochemistry in oncology

    Publicat: 11.07.2024
  11. Thrombosis and cachexia in cancer: Two partners in crime?

    Publicat: 13.06.2024
  12. From clinical and academic culture in radiation oncology - how to cross the chasm?

    Publicat: 30.05.2024
  13. Molecular Classification Predicts Response to Radiotherapy in the Randomized PORTEC-1 and PORTEC-2 Trials for Early-Stage Endometrioid Endometrial Cancer

    Publicat: 16.05.2024
  14. Approach to severe immune-related adverse events: beyond corticosteroids and other challenges

    Publicat: 30.04.2024
  15. Emerging Biomarkers in the Diagnosis and Treatment of Testicular Tumors

    Publicat: 18.04.2024
  16. The World Oncology Forum Amplifies Its Appeal in the Global Fight Against Cancer

    Publicat: 04.04.2024
  17. Immunotherapy options in the 1st line of treatment of Her2 negative advanced GEJ/Gastric Cancer, the role of CPS value

    Publicat: 20.03.2024
  18. An inter-specialty cancer training programme curriculum for Europe

    Publicat: 07.03.2024
  19. Communicating the oncological diagnosis: a psycho-oncological perspective

    Publicat: 22.02.2024
  20. ESMO 2023 Highlights on lung cancer

    Publicat: 08.02.2024

1 / 8

e-ESO is the online platform of the European School of Oncology providing sponsor-free, open access quality education wherever you are in the world. www.e-Eso.net

Visit the podcast's native language site